Downregulation of RRAD in lung cancer leads to increased TNFα-stimulated NF-κB target genes such as MMP9 [21], HIF-1α, and GLUT1 at both protein and mRNA levels [20]. The gene discussed is NFKB1; the disease is lung carcinoma.